Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease
To assess the patterns of angiotensin converting enzyme inhibitors and angiotensin receptor blockers (ACE-I/ARB) discontinuation in the setting of chronic kidney disease (CKD) progression in real-world clinical practice.
Source: Mayo Clinic Proceedings - Category: Internal Medicine Authors: Yao Qiao, Jung-Im Shin, Yingying Sang, Lesley A. Inker, Alex Secora, Shengyuan Luo, Josef Coresh, G. Caleb Alexander, John W. Jackson, Alex R. Chang, Morgan E. Grams Tags: Original article Source Type: research